Cost and perceived need barriers to diabetes eye care

Cost and perceived need barriers to diabetes eye care

(HealthDay)—Cost, lack of insurance, and no need are the most commonly cited reasons why adults with diabetes do not seek annual eye care, according to a study published online Sept. 5 in Diabetes Care.

Chiu-Fang Chou, Dr.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues utilized data from the multi-state 2006 to 2010 Behavioral Risk Factor Surveillance System to identify respondents who had not sought eye care in the previous 12 months. The authors examined the reasons given for skipping recommended vision examinations.

The researchers found that non-adherence to recommended annual eye examinations was 23.5 percent among adults diagnosed with diabetes. "No need" and "cost or lack of insurance" were the most commonly reported reasons for not receiving eye care in the preceding 12 months (39.7 and 32.3 percent, respectively). Adults aged 40 to 64 years were more likely than those aged 65 years and older (relative risk ratios [RRR], 2.79) and women were more likely than men (RRR, 2.33) to report "cost or lack of insurance" as their main reason, even after adjusting for covariates. Younger people (aged 40 to 64 years) were less likely than those over age 65 years to report "no need" (RRR, 0.51) as their main reason.

"Addressing concerns about 'cost or lack of insurance' for adults under 65 years and 'no perceived need' among those 65 years and older could help improve eye care service utilization among people with ," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Team shows why wound healing is impaired in diabetics

Jan 26, 2015

One of the most troubling complications of diabetes is its effect on wound healing. Roughly 15 percent of diabetics will suffer from a non-healing wound in their lifetime. In some cases, these open ulcers on the skin lead ...

Progress in diabetes drug delivery

Jan 22, 2015

A drug therapy for diabetes treatment is being developed by an international research team led by WA scientists, which combines an existing anti-diabetic drug with bile acids to improve the drug's delivery ...

Roux-en-Y surgery can reverse insulin treatment in T2DM

Jan 21, 2015

(HealthDay)—Roux-en-Y gastric bypass surgery (RYGB) strongly predicts insulin cessation after surgery in insulin-treated type 2 diabetes (I-T2D) patients, independent of weight loss, according to a study ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.